These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 32915708

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Optic Nerve Head Volumetry by Optical Coherence Tomography in Papilledema Related to Idiopathic Intracranial Hypertension.
    Dreesbach M, Joachimsen L, Küchlin S, Reich M, Gross NJ, Brandt AU, Schuchardt F, Harloff A, Böhringer D, Lagrèze WA.
    Transl Vis Sci Technol; 2020 Feb 21; 9(3):24. PubMed ID: 32742754
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of peripapillary choroidal thicknesses and optic disc diameters in idiopathic intracranial hypertension.
    Kaya FS, Arici C.
    Can J Ophthalmol; 2023 Jun 21; 58(3):212-218. PubMed ID: 34919841
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis.
    Marzoli SB, Ciasca P, Curone M, Cammarata G, Melzi L, Criscuoli A, Bussone G, D'Amico D.
    Neurol Sci; 2013 May 21; 34 Suppl 1():S143-5. PubMed ID: 23695066
    [Abstract] [Full Text] [Related]

  • 10. Management of the regression of papilledema with regional axon loss in idiopathic intracranial hypertension patients.
    Kabatas N, Eren Y, Nalcacioglu P, Caliskan S, Bicer T, Comoglu SS, Gurdal C.
    Int Ophthalmol; 2021 Apr 21; 41(4):1467-1477. PubMed ID: 33481155
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of retinal vascular and structural alterations in pediatric idiopathic intracranial hypertension patients without papilledema.
    Kocer AM, Yılmaz A, Atesoglu HI, Turkay M, Cıtırık M.
    Photodiagnosis Photodyn Ther; 2023 Jun 21; 42():103608. PubMed ID: 37201770
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
    Huang-Link YM, Al-Hawasi A, Oberwahrenbrock T, Jin YP.
    Clin Neurol Neurosurg; 2015 Mar 21; 130():122-7. PubMed ID: 25614195
    [Abstract] [Full Text] [Related]

  • 14. Can Lumbar Puncture Be Safely Deferred in Patients With Mild Presumed Idiopathic Intracranial Hypertension?
    Vosoughi AR, Margolin EA, Micieli JA.
    J Neuroophthalmol; 2022 Dec 01; 42(4):505-508. PubMed ID: 34860748
    [Abstract] [Full Text] [Related]

  • 15. Impact of weight reduction on structural and functional parameters of the optic nerve in idiopathic intracranial hypertension.
    Banerjee M, Phuljhele S, Saxena R, Sharma P, Misra V, Vibha D, Pandit AK.
    Eur J Ophthalmol; 2024 Sep 01; 34(5):1594-1599. PubMed ID: 38380874
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension.
    Skau M, Yri H, Sander B, Gerds TA, Milea D, Jensen R.
    Graefes Arch Clin Exp Ophthalmol; 2013 Feb 01; 251(2):567-74. PubMed ID: 22592348
    [Abstract] [Full Text] [Related]

  • 18. Use of En Face Optical Coherence Tomography to Monitor Papilledema in Idiopathic Intracranial Hypertension: A Pilot Study.
    Carey AR, Bosley TM, Miller NR, McCulley TJ, Henderson AD.
    J Neuroophthalmol; 2021 Jun 01; 41(2):212-216. PubMed ID: 32235232
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.